市场调查报告书
商品编码
1298694
儿科介入心脏病学市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球儿科介入心脏病学市场规模达到25亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到37亿美元,在2023-2028年期间表现出6.5%的增长率(CAGR)。
小儿介入心脏病学是心脏病学的一个分支,涉及使用特定的基于导管的技术来治疗18岁以下的婴儿、儿童和青少年的心脏疾病。它们包括球囊血管成形术、线圈封堵术、支架植入术和主动脉瓣狭窄。与传统的心脏病治疗相比,小儿介入心脏病学更具有微创性,从而减少手术后的并发症。因此,它们被广泛用于进行血管成形术、瓣膜成形术、冠状动脉血栓切除术和先天性心脏缺陷矫正手术,遍及临床测试实验室、医院、心脏中心和研究机构。
儿童各种先天性心脏病的发生率越来越高,如房间隔缺损(ASD)、房室管缺损、动脉导管未闭(PDA)和室间隔缺损(VSD),这是推动小儿介入心脏病学市场增长的关键因素之一。新颖和更有效的小儿介入心脏病学设备,包括导管、生物可吸收支架、导丝、球囊、支架、血管封闭设备、动脉瘤切除设备的推出,是另一个主要的增长诱导因素。与此相呼应,患者对非侵入性医疗程序的倾向性转变,以及对相关好处认识的提高,如降低感染风险、缩短术后恢复时间和避免大面积疤痕,也推动了市场增长。其他因素,包括医疗支出的增加和各国政府为加快监管程序而采取的许多倡议,都为市场创造了积极的前景。广泛的研究和开发(R&D)活动、消费者医疗保健支出的增加、政府和非政府组织(NGO)为加强现有的医疗保健基础设施而进行的投资以及心脏病学领域的重大技术进步,也是市场的驱动力。
The global pediatric interventional cardiology market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Pediatric interventional cardiology is a subset of cardiology that involves the use of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents upto 18 years of age. They include balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis. As compared to conventional cardiological treatments, pediatric interventional cardiology is more minimally invasive, thus reducing post-surgerycomplications. Consequently, they are extensively employed for performing angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.
Theincreasing instances of various congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD) represent one of the key factors driving the pediatric interventional cardiology market growth. The introduction of novel and more efficient pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, vascular closure devices, atherectomy devices is acting as another major growth-inducing factor.In line with this, the shifting inclination of patients toward non-invasive medical treatment procedures, along with the rising awareness regarding the associated benefits, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars is also driving the market growth. Other factors, including rising healthcare expenditure and the numerous initiatives being undertaken by governments of various nations to speed-up regulatory procedures, are creating a positive outlook for the market. The market is also driven by extensive research and development (R&D) activities, increasing consumer healthcare expenditure and investments by governments and non-government organizations (NGOs) for strengthening the existing healthcare infrastructure, and significant technological advancements in the field of cardiology.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric interventional cardiology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type, procedure and end use.
Closure Devices
Transcatheter Heart Valves
Atherectomy Devices
Catheters
Balloons
Stents
Others
Catheter-Based Valve Implantation
Congenital Heart Defect Correction
Angioplasty
Coronary Thrombectomy
Others
Clinical Testing Laboratories
Hospitals
Cardiac Centers
Pediatric Clinics
Research Institutions
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
Key Questions Answered in This Report
1. What was the size of the global pediatric interventional cardiology market in 2022?
2. What is the expected growth rate of the global pediatric interventional cardiology market during 2023-2028?
3. What are the key factors driving the global pediatric interventional cardiology market?
4. What has been the impact of COVID-19 on the global pediatric interventional cardiology market?
5. What is the breakup of the global pediatric interventional cardiology market based on the device type?
6. What are the key regions in the global pediatric interventional cardiology market?
7. Who are the key players/companies in the global pediatric interventional cardiology market?